NE-3107 Alzheimer's, Parkinson's data boost Biovie

BioVie blames trial sites for phase 3 Alzheimer's drug fail

Jnana Therapeutics describes new SLC6A19 inhibitors

Saniona and Astronautx establish research collaboration in Alzheimer's disease

BioVie achieves revised enrolment target in Alzheimer's trial

NX-019 shows potency and selectivity in preclinical models of EGFR-mutant tumors

Symbio enters sponsored research agreement to study brincidofovir in HSV-infected brain tissue model

BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock

BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock

Antioxidants, Free Full-Text

Wearable BioWorld

Researchers demonstrate e-stim reduces neural damage from strokes